Creative Planning’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Creative Planning’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,000	Closed	-$18.1K	–	3084
2023 Q2	$18.1K	Hold	10,000	–	–	﹤0.01%	2511
2023 Q1	$13.2K	Buy	+10,000	New	+$16.4K	﹤0.01%	2445

Other funds holding PRDS

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Creative Planning's PRDS Position: Q3 2023 in Review

Creative Planning sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 10,000 shares — an estimated $18.1K sold.

Creative Planning first reported a position in PRDS in Q1 2023 and held it in 2 quarters. The position peaked at $18.1K in Q2 2023. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

Creative Planning reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Creative Planning sold 10,000 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $18.1K.
Creative Planning first reported a position in Pardes Biosciences, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
Creative Planning's Pardes Biosciences, Inc. Common Stock position peaked at $18.1K in Q2 2023.
1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on Creative Planning's 13F filing for Q3 2023, filed 16 Nov 2023.